SIF

Poster Session Abstracts
P-XI - Pharmacogenetics, Pharmacogenomics and Gene Therapy; Personalised medicine and biomarkers


HSA-MIR-196A2 AND DICER: NEW POSSIBLE PLAYERS IN THE PHARMACOGENETICS OF RECTAL CANCER?
Polesel J., De Paoli A., Agostini M., Pucciarelli S., De Marchi F., Giodini L., Posocco B., De Santa J., Gagno S., Zanusso C., De Mattia E., Toffoli G., Cecchin E., Dreussi E.
A POSSIBLE ASSOCIATION BETWEEN DPYD*2A AND THE ONSET OF SEVERE TOXICITY IN PATIENTS TREATED WITH FLUOROPYRIMIDINE: PRELIMINARY RESULTS AND POSSIBLE CLINICAL IMPLICATIONS
Giodini L., Cecchin E., Lo Re G., Buonadonna A., Pella N., Tirelli U., Berretta M., Lonardi S., Sartor F., Rizzolio F., Gagno S., De Santa J., Posocco B., Dreussi E., Toffoli G.
CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): ROLE OF POLYMORPHISMS IN THE GST-µ, GST-θ GENES ON TOXICITY AND STEROID APOPTOSIS
Franca R., Houedjakou A., Granzotto M., Zanut A., Stocco G., Rebora P., Valsecchi M., Rabusin M., Decorti G.
NONCODING RNA GAS 5 AS MARKER FOR PREDICTING RESPONSE TO GLUCOCORTICOIDS
Lucafò M., De Iudicibus S., Di Silvestre A., Pelin M., Piscianz E., Tommasini A., Decorti G.
PHARMACOLOGICAL STRATEGIES FOR PREDICTION OF GLUCOCORTICOID RESPONSE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
De Iudicibus S., Lucafò M., Di Silvestre A., Ventura A., Decorti G.
RELATIONSHIP BETWEEN STATIN-RELATED CREATINE KINASE ELEVATIONS AND GENETIC POLYMORPHISMS OF ABCB1, ABCG2 AND SLCO1B1 TRANSPORTERS
Ferrari M., Guasti L., Marino F., Serratì M., Contini S., Grandi A., Cosentino M.
ANALYSIS OF NEW POLGLUMYT® DERIVATIVES AS NANOCARRIER FOR EFFICIENT INTRACELLULAR SIRNA DELIVERY
Bartella C., Apicella C., D'Atanasio N., Vitiello M., Liberati E., Russo V., Corazzari M., Capezzone de Joannon A., Mangano G., Tongiani S.
THE ROLE OF PHARMACOMETRICS IN UNRAVELING THE EFFECT OF HOCT1 POLYMORPHISM C.480C>G ON THE PHARMACOKINETICS OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA
Polillo M., Galimberti S., Capecchi M., Baratè C., Cervetti G., Guerrini F., Ciabatti E., Lastella M., Bocci G., Petrini M., Danesi R., Di Paolo A.
ANALYSIS OF UGT1A1*28 AND DPYD*2A POLYMORPHISMS IN SICILIANS PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH IRINOTECAN AND 5-FLUOROURACIL.
Labbozzetta M., Vivona N., Poma P., Notarbartolo M., D'Alessandro N.
RESEQUENCING OF SPERMIDINE/SPERMINE N1-ACETYLTRANSFERASE (SAT1) PROMOTER REGION IN BIPOLAR SUICIDE COMPLETERS AND HEALTHY CONTROLS.
Niola P., Gross J., Chillotti C., Deiana V., Pisanu C., Severino G., Turecki G., Alda M., Del Zompo M., Squassina A.
SINGLE NUCLEOTIDE POLYMORPHISMS OF ABCB1 GENE INFLUENCE ON INTRACELLULAR CONCENTRATIONS OF DASATINIB.
Pirro E., De Francia S., D'Avolio A., Ariaudo A., Simiele M., Cusato J., Fava C., Baietto L., Di Perri G., Saglio G.
ASIC2A OVEREXPRESSION INCREASES LITHIUM-INDUCED INHIBITION OF GSK3ß
Costa M., Faucon Biguet N., Roussel J., Ravassard P., Sestu M., Congiu D., Squassina A., Del Zompo M., Meloni R.
A STRATEGY TO SELECT POLYMORPHISMS WITH POTENTIAL IMPACT ON CLINICAL PHENOTYPES USING OPEN-SOURCE BIOINFORMATIC TOOLS
Gagno S., Rizzolio F., Zanusso C., Boffo S., Dreussi E., Sartor F., Giorda G., Toffoli G.
HYDROGEN SULPHIDE IS INVOLVED IN HUMAN MALIGNANT HYPERTERMIA
Bucci M., Vellecco V., Di Martino A., Attanasio C., Andria B., Panza E., Ianaro A., Mancini A., Cirino G.
FACTOR XIII VAL 34 LEU POLYMORPHISM AND MIGRAINE
Pizza V., Infante F., Schiavo G., Mallamaci V., Agresta A., Colucci D'Amato C., Capasso A.
APOLIPOPROTEIN E GENE POLYMORPHISMS AND MIGRAINE
Pizza V., Infante F., Agresta A., Mallamaci V., Colucci D'Amato C., Capasso A., Schiavo G.
THE COMT VAL158MET POLYMORPHISM MODULATES IN AN OPPOSITE-DIRECTION THE CLINICAL RESPONSE TO INTRATHECAL MORPHINE AND TRIPTANS
Cargnin S., Magnani F., Viana M., Tassorelli C., Sances G., Nappi G., Canonico P., Genazzani A., Raffaeli W., Terrazzino S.
UNVEILING OF BRAF V600E MUTANT CELLS SENSITIVITY TO PROTEASOME INHIBITORS USING AN ISOGENIC CELL BASED SCREENING
Boscaro V., Zecchin D., Bardelli A., Di Nicolantonio F., Gallicchio M.
INFLUENCE OF THE CYP2B6 POLYMORPHISM ON THE PHARMACOKINETICS OF MITOTANE.
De Francia S., Basile V., D'Avolio A., De Martino F., Pirro E., Ardito A., Zaggia B., Piccione F., Cusato J., Terzolo M.
CHANGES IN BDNF EXPRESSION AND DENDRITIC TRAFFICKING OF SELECT BDNF TRANSCRIPTS LINKED TO EPIGENETIC CHANGES IN BDNF VAL66MET MICE
Mallei A., Corna S., Baj G., Ieraci A., Tardito D., Lee F., Racagni G., Tongiorgi E., Popoli M.
RELATIONSHIP BETWEEN ABCB1 AND ABCG2 GENETIC POLYMORPHISM AND RESISTANCE TO CLOPIDOGREL TREATMENT AFTER PERCUTANEOUS CORONARY INTERVENTION
Ferrari M., Tozzi M., Marino F., Mirabile M., Novy C., Tarallo A., Riva F., Castelli P., Cosentino M.
CAD PATIENTS WITH RENAL INSUFFICIENCY: INSIGHTS INTO THEIR PLATELET PROTHROMBOTIC, TRANSCRIPTOMIC AND PROTEOMIC PROFILE
Canzano P., Brambilla M., Brioschi M., Piacentini L., Rossetti L., Marenzi G., Banfi C., Teruzzi G., Bono E., Trabattoni D., Colombo G., De Metrio M., Bartorelli A., Tremoli E., Camera M.
PLATELET ACTIVATION IN CAD PATIENTS WITH TYPE-2 DIABETES MELLITUS: INSIGHTS INTO THEIR PROTHROMBOTIC PROPENSITY
Rossetti L., Brambilla M., Canzano P., Piacentini L., Trabattoni D., Bono E., Teruzzi G., Colombo G., Marenzi G., Rubino M., Bartorelli A., Tremoli E., Camera M.
INFLUENCE OF GENETIC POLYMORPHISMS IN CYP11B2, AGT, AND AGTR1 GENES ON HYPERTENSION AND DRUG TREATMENT IN A POPULATION SAMPLE OF THE EMILIA-ROMAGNA REGION
Angelini S., Rosticci M., Massimo G., Cicero A., Borghi C., Cantelli Forti G., Hrelia P.
PHARMACOGENETIC DETERMINANTS OF RESPONSE TO METHOTREXATE IN JUVENILE IDIOPATHIC ARTHRITIS
Stocco G., Pastore S., Moressa V., Zandonà L., Favretto D., Lepore L., Decorti G.
BRACHIAL ARTERY DIAMETER ENLARGEMENT: A NEW MARKER OF ATHEROSCLEROSIS?
Amato M., Sansaro D., Ravani A., Frigerio B., Castelnuovo S., Veglia F., Tremoli E., Baldassarre D.
EVALUATION OF THE MRNA EXPRESSION RESPONSE AS A NOVEL IN VITRO TOOL FOR ASSESSING SENSITIVITY TO STEROID TREATMENT
Cuzzoni E., de Vaal Y., Anholts J., Decorti G., Claas F., Eikmans M.
ANALYTICAL METHOD DEVELOPMENT FOR A PHARMACOKINETIC-PHARMACOGENETIC PLATFORM AIMED TO OPTIMIZE SMOKING CESSATION PHARMACOTHERAPIES
Fogli S., Saba A., Del Re M., Carrozzi L., Pistelli F., Palla A., Zucchi R., Breschi M., Danesi R.
THE ROLE OF THERAPEUTIC MONITORING OF MYCOPHENOLIC ACID IN DIABETIC PATIENTS RECEIVING A PANCREAS-KIDNEY TRANSPLANT
Di Paolo A., Ciofi L., Polillo M., Sarli V., Lastella M., Bocci G., Danesi R.
FUNCTIONAL ANALYSIS OF MEL-18 AND BMI-1 IN DIFFERENT BREAST CANCER SUB-TYPES
Paolicchi E., Brignatz-Guittard C., Crea F., Danesi R., Green J.
CIRCULATING TUMOR CELLS DETECTION IN PATIENTS WITH ADRENOCORTICAL CANCER.
Geninatti K., De Francia S., Aroasio E., Taberna E., Sperone P., Terzolo M., Scagliotti G.
DEVELOPMENT AND VALIDATION OF A KIT FOR THE DETECTION OF THE PML-RARA BCR2 FUSION TRANSCRIPT FOR MONITORING OF ACUTE PROMYELOCYTIC LEUKEMIA
Schiavo I., Anselmi A., Sessa F., Mason S., Cignarella A.
DETECTION OF BRAF AND KRAS MUTATIONS IN DNA RELEASED BY TUMORS IN PERIPHERAL BLOOD BY AN ADVANCED DIGITAL DROPLET PCR
Del Re M., Bianchi M., Martinetti A., Antoniotti C., Ulivi P., Marconcini R., Pietrantonio F., Schirripa M., Sottotetti E., Loupakis F., Tesei A., Zoli W., De Braud F., Amadori D., Falcone A., Danesi R.
MULTICOLOR FLOW CYTOMETRY ANALYSIS OF MICROPARTICLES IN WHOLE BLOOD REVEALS SIGNIFICANT DIFFERENCES COMPARED TO ANALYSIS PERFORMED IN PLATELET FREE PLASMA
Boselli D., Brambilla M., Manganaro D., Tremoli E., Camera M.
IDENTIFICATION OF HUMAN LUNG LYMPHATIC ENDOTHELIAL CELLS AS POTENTIAL TARGETS OF INFLAMMATORY AND NEOPLASTIC DISEASES
Lorusso B., Madeddu D., Falco A., Frati C., Giovannelli G., Maselli D., Facchinetti F., Rinaldi L., Lagrasta C., Quaini E., Ampollini L., Carbognani P., Rusca M., Quaini F.
THE GPNMB/OA PROTEIN INCREASED THE INVASIVENESS CAPABILITY OF HUMAN METASTATIC PROSTATE CANCER CELLS DU145 AND PC3 THROUGH THE ACTIVITY OF MMP-2 AND MMP-9
Bodei S., Fiorentini C., Bedussi F., Fragni M., Simeone C., Zani D., Cosciani Cunico S., Missale C., Spano P., Sigala S.